| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/14/2005 | US6906193 N-type calcium channel antagonists for the treatment of pain |
| 06/14/2005 | US6906166 Multicolor; light emitting diodes; polyarylenevinylenes |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness |
| 06/14/2005 | CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners |
| 06/09/2005 | WO2005051915A1 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 06/09/2005 | WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051901A1 Anti-cancer agents |
| 06/09/2005 | WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 06/09/2005 | US20050124655 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124652 Guanidino compounds |
| 06/09/2005 | US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 06/09/2005 | US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 06/09/2005 | US20050124626 Novel compounds |
| 06/09/2005 | US20050124611 Such as N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]-4-morpholineacetamide; potassium channel modulators |
| 06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 06/09/2005 | DE10353910A1 Verfahren zur Synthese optisch aktiver Piperidine Process for the synthesis of optically active piperidines |
| 06/09/2005 | CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545786A1 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 06/09/2005 | CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545659A1 Bicyclic inhibitors of mek |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
| 06/08/2005 | EP1536684A2 Method for the prevention and/or treatment of atherosclerosis |
| 06/08/2005 | CN1625550A Process for the manufacture of organic compounds |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903133 Anticancer compounds |
| 06/07/2005 | US6903114 Carbocyclic alcohols such as 1,6-dinitronaphthalene-2,3-diol, used as catechol-O-methyltransferase inhibitors, for prophylaxis of Parkinson's disease |
| 06/07/2005 | US6903094 As analgesic |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049575A1 Novel method of preparing 3-fluorinated quinolines |
| 06/02/2005 | WO2005049570A1 Method for synthesising optically active piperidines by the hydrogenation of optically active pyridines |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005048953A2 Amide derivatives as kinase modulators |
| 06/02/2005 | WO2005048948A2 Urea derivatives as kinase modulators |
| 06/02/2005 | WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/02/2005 | WO2005030792A3 Quinoline potassium channel inhibitors |
| 06/02/2005 | US20050119487 Naphthol derivative and charge control agent comprising the same |
| 06/02/2005 | US20050119453 Method of removing transition metals |
| 06/02/2005 | US20050119269 Heterocyclic compounds and methods of making and using thereof |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 06/02/2005 | CA2545711A1 Urea derivatives as kinase modulators |
| 06/01/2005 | EP1535910A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534681A1 Substituted quinoline ccr5 receptor antagonists |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | CN1622938A 方法 Method |
| 06/01/2005 | CN1622937A Process for the manufacture of HMG-coa reductase inhibitors |
| 06/01/2005 | CN1204122C Process for separating optically active ethyl (3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3, 5-dihydroxy-6-heptenoate |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/31/2005 | CA2195776C Novel process for the preparation of diisopinocampheylchloroborane |
| 05/26/2005 | WO2005047262A1 Crystalline form of gatifloxacin |
| 05/26/2005 | WO2005047261A1 Non-hygroscopic crystalline form of gatifloxacin |
| 05/26/2005 | WO2005047260A1 Process for preparing gatifloxacin |
| 05/26/2005 | WO2005047259A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
| 05/26/2005 | WO2005047258A2 Methods and compositions for selectin inhibition |
| 05/26/2005 | WO2005047257A2 Methods and compositions for selectin inhibition |
| 05/26/2005 | WO2005047231A1 Non-symmetrical gelling agent |
| 05/26/2005 | WO2005046693A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005030678A3 AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS |
| 05/26/2005 | WO2005030129A3 Quinoline potassium channel inhibitors |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113411 Amino-substituted ethylamino beta2 adrenergic receptor agonists |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders |
| 05/26/2005 | US20050112406 Organometallic complexes and organic electroluminescence device using the same |
| 05/26/2005 | CA2544814A1 Non-symmetrical gelling agent |
| 05/26/2005 | CA2544693A1 Methods and compositions for selectin inhibition |
| 05/26/2005 | CA2543765A1 Methods and compositions for selectin inhibition |
| 05/26/2005 | CA2543163A1 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532114A2 Process for preparing quinolone antibiotic intermediates |
| 05/25/2005 | EP1532113A2 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 05/25/2005 | DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |